23andMe Holding Co. Class A Common Stock (ME) Social Stream
23ANDME HOLDING CO (ME) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering 23ANDME HOLDING CO.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 143 days, ME's average price target has gone up $0.83.
ME reports an average of 63.86% for its upside potential over the past 37 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ME Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
ME's average broker recommendation rating improved by 1.33 over the prior 19 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how 23ANDME HOLDING CO fares relative to all US stocks, note that its number of analysts covering the stock is greater than 20.45% of that group.
- In the context of stocks in the mid market cap category, 23ANDME HOLDING CO's average analyst price target is greater than 49.02% of them.
- In terms of how 23ANDME HOLDING CO fares relative to stocks in the mid market cap category, note that its variance in analysts' estimates is lower than -122.91% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, 23ANDME HOLDING CO's upside potential (average analyst target price relative to current price) is greater than 538.75% of them.
Stocks similar to 23ANDME HOLDING CO in the Pharmaceutical Products industry regarding analyst recommendations and price targets are STTK, ROIV, and PRAX.
View All Top Stocks by Price Target
Is ME a Buy, Hold or Sell? See the POWR Ratings now!